Such immunosuppressive effects have been observed not only in CRC, but also in breast cancer (BC) and ESCC, where F. nucleatum suppresses T cell function and upregulates PD‐L1, thereby impairing immunotherapy efficacy [141, 142, 143]. Here, CD274 is linked to breast cancer.